FGSC #302

Mutant Type

Genus: N

reporting_genes: Has been replaced by strain number: 1195

species: Neurospora crassa

allele: Y31881 B234

stock: 7067

glasgow:

mutagen:

Depositor: DDP

Link Group:

MT: a

Species No: 10

gene_back:

oppmt: 0

trans:

ref1: https://www.genetics.org/content/44/6/1185.long

ref2: 1960 mimeo sheet accompaning 1959 Genetics paper

site:

country:

ksudc_link: https://digital.lib.k-state.edu/item/neurospora-crassa/fgsc-302

Locus	Cultural Requirements	Link Group	Type
nic-3	VIIL. Right of spco-4 (1%) and do (3%). Left of thi-3 (9 to 27%) and csp-2 (16 to 22%) (539, 812, 816, PB). (M.K. Allen, cited in references 718 and 789) Uses nicotinic acid, nicotinamide, 3-hydroxyanthranilic acid, 3-hydroxykynurenine, or high concentrations of quinolinic acid (96, 1168). Accumulates alpha-N-acetylkynurenine; blocked in conversion of kynurenine to 3-hydroxykynurenine (1168) (Fig. 18). Pyridine nucleotide levels (111). Pathway from tryptophan to nicotinic mononucleotide, showing sites of gene action (96, 100, 368, 1168). The enzymatic reactions between 3-hydroxyanthranilate and nicotinic mononucleotide have not been demonstrated directly in Neurospora.	VIIL	B
sk	VIIR. Right of nt (7 to 17%) (789). Leathery, nonconidiating rapid surface growth (789). "Mucilaginous substrate hyphae" (1088). sk ascospores are slow to mature, but good allele ratios are obtained from crosses held for 3 weeks at 25°C. Female sterile. Allele R2466 called mo-3; alleles Y6821, R2408, and R2529 called moe-1(382, PB).	VIIR	B

Neurospora Crassa Wikipedia